SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1,417.33 |
Enterprise Value ($M) | 1,253.22 |
Book Value ($M) | 443.59 |
Book Value / Share | 12.83 |
Price / Book | 3.20 |
NCAV ($M) | 440.43 |
NCAV / Share | 12.74 |
Price / NCAV | 3.22 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.23 |
Return on Assets (ROA) | -0.31 |
Return on Equity (ROE) | -0.32 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 21.17 |
Current Ratio | 21.17 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 493.62 |
Assets | 496.77 |
Liabilities | 53.19 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -129.72 |
Net Income | -109.36 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -93.93 |
Cash from Investing | -292.33 |
Cash from Financing | 218.31 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Orbimed Advisors Llc | 4.50 | -12.84 | |
13D/A | Ai Dmi Llc | 10.80 | 0.00 | |
13G/A | Bain Capital Life Sciences Opportunities III, LP | 3.30 | -45.23 | |
13G | Fmr Llc | 6.30 | -13.87 | |
13G/A | Wellington Management Group Llp | 4.70 | -24.17 | |
13G/A | Paradigm Biocapital Advisors LP | 5.04 | -37.23 | |
13G | BlackRock, Inc. | 6.20 | 0.00 | |
13G | Frazier Life Sciences Public Fund, L.P. | 5.90 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
108,919 | 307,504 | 35.42 | |
198,883 | 498,248 | 39.92 | |
103,193 | 369,529 | 27.93 | |
95,916 | 344,438 | 27.85 | |
(click for more detail) |
Similar Companies | |
---|---|
IKNA – Ikena Oncology, Inc. | IMRX – Immuneering Corporation |
IOVA – Iovance Biotherapeutics, Inc. | ITOS – iTeos Therapeutics, Inc. |
IVVD – Invivyd, Inc. |
Financial data and stock pages provided by
Fintel.io